[ad_1]
Johnson & Johnson (J & J) will include information on the cost of its drugs in direct-to-consumer pharmaceutical advertising. In a press release, it was announced that it would include both the list price and any fees for patients.
This follows the American Patients First project of the Administration, published last May, which proposed to include catalog price information in consumer TV commercials. The pharmaceutical giant said it plans to put in place additional transparency to allow patients to make more informed decisions.
According to J & J, pricing information will provide patients with clearer and more valuable information about the cost of drugs advertised on television. The company will start with its widely prescribed drug, to evaluate how price and cost information will be received by a wide range of people. It will also consider the reactions of patients and consumers to guide the deployment of new drugs advertised on television.
Last month, J & J unveiled its financial results for the fourth quarter of 2018, with sales of US $ 20.4 billion. It also experienced a 1.0% increase over the fourth quarter of 2017. In addition, its operating results increased by 3.3% and the negative impact of the currency was 2.3%. The company reported domestic sales up 1.5%, while international sales rose 0.4%. It also reflects an operating growth of 5.1% and a negative currency effect of 4.7%.
Alex Gorsky, chief executive officer of Johnson & Johnson, said the company had another year of strong growth in its operational revenue of 6.3% and realized its growth in adjusted operating income for the 35th year-on-year to 9.8% in 2018. Based on fourth quarter results This can be attributed to the acceleration of underlying sales performance in each of its businesses, where it also leveraged its scale throughout the year. Company to improve margins.
"For the future, the strength of our broad enterprise and our disciplined approach to portfolio management allows us to continue to drive innovation investments, enabling us to leverage strategic opportunities and achieve solid long-term performance, "added Gorsky.
[ad_2]
Source link
